FDA Import Refusal SCS-8392299-1/11/1 — Intas Pharmaceuticals Limited
The FDA refused shipment SCS-8392299-1/11/1 from Intas Pharmaceuticals Limited (India) on Mar 26, 2025. The refused product falls under Drugs and Biologics — LITHIUM CITRATE (ANTI-DEPRESSANT). Cited charge: 27 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Mar 26, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61NCB71 LITHIUM CITRATE (ANTI-DEPRESSANT)
- Charges
- 27